Examination of Mel-frequency Cepstral Coefficients features for Parkinson's Disease telediagnosis

dc.contributor.authorMasunda, Sam
dc.contributor.authorHarisudha, Kuresan
dc.contributor.authorSamiappan, Dhanalakshmi
dc.date.accessioned2023-06-29T07:39:53Z
dc.date.available2023-06-29T07:39:53Z
dc.date.issued2017-11-16
dc.description.abstractThe focus for 5G networks is on high fidelity networks with extreme precision, making complete telediagnostic and telehealth realizations a possibility. The characterization of Parkinson’s disease (PD) is based on motor and non-motor functions of the body. Speech issues in PD patients identify with motor control, not to lost the phonetic learning required to make prosodic qualifications. Speech discourse issues are referred to as one of the most punctual markers for PD and clinical conclusion takes up to five years to identify PD. This means s pitch can be used as one of the biomarkers for PD. Attention is given to prosodic, spectral, vocal tract and excitation source speech features. Fundamental frequency, Pitch Period Entropy (PPE), jitter, shimmer, Melfrequency Cepstral Coefficients (MFCC) and Hidden Markov Model (HMM) are the parameters used in this respecten_US
dc.identifier.citationMasunda, S. Harisudha. K & Samiappan, D. 2018. Examination of Mel-frequency Cepstral Coefficients features for Parkinson's Disease telediagnosis.en_US
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/876
dc.language.isoenen_US
dc.publisher30th GISFI Standardisation Series Meeting and IEEE 5G Summit,en_US
dc.relation.ispartofseries30th GISFI Standardisation Series Meeting and IEEE 5G Summit,;Volume 6
dc.subjectbiomarker; feature extraction, Parkinson’s disease, speech features; speech signal; telediagnosis; telehealth;en_US
dc.titleExamination of Mel-frequency Cepstral Coefficients features for Parkinson's Disease telediagnosisen_US
dc.typeWorking Paperen_US

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Examination of Mel-frequency Cepstral Coefficients features for Parkinson_s Disease.pdf
Size:
2.55 MB
Format:
Adobe Portable Document Format
Description:
Working paper

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: